Trials / Completed
CompletedNCT03355235
Brilliant Study: Assessing Cognition in Myeloma Patients Undergoing Transplant
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The overall objectives in this study are to identify patterns of cognitive impairment pre- and post-transplant, to assess the similarities of scores of the three cognitive assessments in myeloma patients who undergo autologous stem cell transplant, and to determine if patients prefer the self-assessment, Self-Administered Gerocognitive Exam (SAGE) or the healthcare applied Montreal Cognitive Assessment (MoCA) assessment.
Detailed description
The overall objectives in this study are to identify patterns of cognitive impairment pre- and post-transplant, to assess the similarities of scores of the three cognitive assessments in myeloma patients who undergo autologous stem cell transplant, and to determine if patients prefer the self-assessment, Self-Administered Gerocognitive Exam (SAGE) or the healthcare applied Montreal Cognitive Assessment (MoCA) assessment.
Conditions
Timeline
- Start date
- 2017-10-20
- Primary completion
- 2019-07-10
- Completion
- 2019-08-27
- First posted
- 2017-11-28
- Last updated
- 2020-08-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03355235. Inclusion in this directory is not an endorsement.